Last updated on May 2020

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks

Brief description of study

The reason for this study is to see how effective and safe the study drug known as lasmiditan is in the acute treatment of 4 migraine attacks with or without aura.

Clinical Study Identifier: NCT03670810

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.